Association between core mutations and annual decline rate of HBVDNA and HBsAg in chronic hepatitis B patients treated with nucleoside analogue

被引：0
|
作者：
Honda, Takashi [1 ]
Ishigami, Masatoshi [1 ]
Ito, Takanori [1 ]
Ishizu, Yoji [1 ]
Kuzuya, Teiji [1 ]
Fujishiro, Mitsuhiro [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med Gastroenterol & Hepatol, Nagoya, Aichi, Japan
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30488-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-215
引用
收藏
页码：E258 / E258
页数：1
相关论文
共 50 条
  • [41] Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon
    Boglione, Lucio
    Cusato, Jessica
    Cariti, Giuseppe
    Di Perri, Giovanni
    D'Avolio, Antonio
    ANTIVIRAL RESEARCH, 2016, 136 : 32 - 36
  • [42] Association between ALT flares and HBeAg loss and HBsAg decline in Patients with Chronic Hepatitis B during treatment with Tenofovir Disoproxil Fumarate or Adefovir Dipivoxil
    Marcellin, Patrick
    Gane, Edward J.
    Krastev, Zahary
    Gurel, Selim
    Dusheiko, Geoffrey M.
    Gaggar, Anuj
    Massetto, Benedetta
    Kim, Kyungpil
    Flaherty, John F.
    Subramanian, Mani
    Janssen, Harry L.
    Buti, Maria
    HEPATOLOGY, 2015, 62 : 1212A - 1212A
  • [43] HBsAg decline after interrupting nucleos(t)ide analogue therapy in HVeAg-negative chronic hepatitis B
    Siederdissen, C. Hoener zu
    Rinker, F.
    Falk, C. S.
    Filmann, N.
    Maasoumy, B.
    Deterding, K.
    Port, K.
    Mix, C.
    Herrmann, E.
    Wedemeyer, H.
    Manns, M. P.
    Kraft, A. R. M.
    Cornberg, M.
    JOURNAL OF CLINICAL VIROLOGY, 2015, 69 : 233 - 233
  • [44] HEMATOPOIETIC CHANGES, HBSAG AND HBVDNA DETECTION IN PROGENITOR-CELL CULTURES OF PATIENTS WITH CHRONIC ACTIVE HEPATITIS-B
    GEISSLER, D
    GAGGL, S
    HEROLD, M
    VOGEL, W
    HEPATOLOGY, 1990, 12 (04) : 963 - 963
  • [45] Nucleoside analogue treatment can not reduce the incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Yasunaka, Tetsuya
    Ikeda, Fusao
    Wada, Nozomu
    Morimoto, Yuuki
    Kuwaki, Kenji
    Takaki, Akinobu
    Yamamoto, Kazuhide
    HEPATOLOGY, 2013, 58 : 671A - 671A
  • [46] Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients
    Xiao-Ling Wang
    Jian-Ping Ren
    Xue-Qing Wang
    Xiao-Hong Wang
    Shao-Fang Yang
    Yi Xiong
    World Journal of Gastroenterology, 2016, (11) : 3268 - 3274
  • [47] Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients
    Wang, Xiao-Ling
    Ren, Jian-Ping
    Wang, Xue-Qing
    Wang, Xiao-Hong
    Yang, Shao-Fang
    Xiong, Yi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (11) : 3268 - 3274
  • [48] Association between the viral basal core promoter and precore mutations with the different clinical stages of patients with chronic Hepatitis B virus infection
    Daud, N. A.
    Parewangi, L. A.
    Turyadi, T.
    Ie, S. I.
    Zulkifli, A. A.
    Akil, F.
    Massi, M. N.
    Bakri, S.
    Muljono, D. H.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 32 - 32
  • [49] HBsAg seroconversion in adefovir dipivoxil (ADV) treated chronic hepatitis B (CHB) patients
    Shiffman, M
    Marcellin, P
    Jeffers, L
    Gordon, S
    Peters, M
    Rizzetto, M
    Buggisch, P
    Vetter, D
    Choy, GS
    Westland, C
    Arterburn, S
    Currie, G
    Brosgart, CL
    JOURNAL OF HEPATOLOGY, 2004, 40 : 17 - 17
  • [50] Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon α-2b for 48 weeks
    Tan, Zhili
    Kong, Nan
    Zhang, Qiran
    Gao, Xiaohong
    Shang, Jia
    Geng, Jiawei
    You, Ruirui
    Wang, Tao
    Guo, Ying
    Wu, Xiaoping
    Zhang, Wenhong
    Qu, Lihong
    Zhang, Fengdi
    HEPATOLOGY INTERNATIONAL, 2024, : 358 - 367
12345